TMCnet - World's Largest Communications and Technology Community



Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of Galena Biopharma, Inc.
[February 14, 2014]

Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of Galena Biopharma, Inc.

BENSALEM, Pa. --(Business Wire)--

Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Galena Biopharma, Inc. ("Galena" or the "Company") (NASDAQ:GALE) concerning possible violations of federal securities laws. The investigation focuses on certain statements issued by the Company concerning Galena's operations.

Galena focuses on developing oncology treatments to address major unmet medical needs to advance cancer care, and is developing immunotherapy product candidats for the treatment of various cancers based on the E75 peptide. The investigation is related to an article published February 12, 2014, on the financial website TheStreet, alleging that Galena has engaged in a misleading "brand awareness campaign designed to boost Galena's stock price." The article claims that the Company hired a stock-promotions firm to tout Galena stock but some of the firm's marketing tactics "appear to resemble stock promotion schemes which run afoul of standard investor relations practices." TheStreet article further claims that Galena insiders have made millions of dollars by selling Company stock in January.

If you purchased Galena shares, if you have information or would like to learn more about these claims, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to, or visit our website at

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy